NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

“Wonder if London has been using the exact same process as in the trial, and that is the reason it is still open. Not for capacity, but for a reference process.” — ex

That’s what I think, and let’s be real, Dr. Ashkan is probably still the point man on all U.K. specials, so there is a bottleneck of sorts there. Without advertising, and advertising being even more constrained premarket due to specials, the 47% increase in specials is de minimus but not insignificant given the current unreimbursed status and relative silence.